Enhancement of brown fat thermogenesis using chenodeoxycholic acid in mice

International Journal of Obesity

Volumn 38, Issue 8, 2014, Pages 1027-1034

  Teodoro, J S ^a,b   Zouhar, P ^c   Flachs, P ^c   Bardova, K ^c   Janovska, P ^c   Gomes, A P ^a,b   Duarte, F V ^a,b   Varela, A T ^a,b   Rolo, A P ^a,d   Palmeira, C M ^a,b   Kopecky J ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^d UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

white adipose tissue; uncoupling protein 1; energy expenditure; bile acids

Indexed keywords

CHENODEOXYCHOLIC ACID; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN;

ANIMAL; BROWN ADIPOSE TISSUE; C57BL MOUSE; ENERGY METABOLISM; GLUCOSE INTOLERANCE; LIPID DIET; LIPID METABOLISM; MALE; METABOLISM; MOUSE; MOUSE MUTANT; OBESITY; OXIDATIVE STRESS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THERMOGENESIS; WESTERN BLOTTING; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; BLOTTING, WESTERN; CHENODEOXYCHOLIC ACID; DIET, HIGH-FAT; ENERGY METABOLISM; GLUCOSE INTOLERANCE; ION CHANNELS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MITOCHONDRIAL PROTEINS; OBESITY; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THERMOGENESIS;

EID: 84905663740     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.230     Document Type: Article

References (43)

1. Angelin B, Einarsson K, Hellstrom K, Leijd B. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J Lipid Res 1978; 19: 1017-1024. (Pubitemid 9059813)
2. Teodoro JS, Rolo AP, Palmeira CM. Hepatic FXR: Key regulator of whole-body energy metabolism. Trends Endocrinol Metab 2011; 22: 458-466.
3. Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 2004; 113: 1408-1418. (Pubitemid 39071696)
4. Kast HR, Nguyen CM, Sinal CJ, Jones SA, Laffitte BA, Reue K et al. Farnesoid X-Activated receptor induces apolipoprotein C-II transcription: A molecular mechanism linking plasma triglyceride levels to bile acids. Mol Endocrinol 2001; 15: 1720-1728. (Pubitemid 32939302)
5. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102: 731-744.
6. Stayrook KR, Bramlett KS, Savkur RS, Ficorilli J, Cook T, Christe ME et al. Regulation of carbohydrate metabolism by the farnesoid X receptor. Endocrinology 2005; 146: 984-991. (Pubitemid 40289284)
7. Cariou B, Van Harmelen K, Duran-Sandoval D, Van Dijk TH, Grefhorst A, Abdelkarim M et al. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 2006; 281: 11039-11049. (Pubitemid 43855527)
8. Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, Van Dijk TH et al. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem 2005; 280: 29971-29979. (Pubitemid 41177076)
9. Abdelkarim M, Caron S, Duhem C, Prawitt J, Dumont J, Lucas A et al. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-Activated receptor-gamma and interfering with the Wnt/ beta-catenin pathways. J Biol Chem 2010; 285: 36759-36767.
10. Watanabe M, Morimoto K, Houten SM, Kaneko-Iwasaki N, Sugizaki T, Horai Y et al. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PloS One 2012; 7: E38286.
11. Konikoff FM. Gallstones-Approach to medical management. MedGenMed 2003; 5: 8.
12. Prawitt J, Caron S, Staels B. Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep 2011; 11: 160-166.
13. Katona BW, Cummins CL, Ferguson AD, Li T, Schmidt DR, Mangelsdorf DJ et al. Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids. J Med Chem 2007; 50: 6048-6058.
14. Neuschwander-Tetri BA. Farnesoid x receptor agonists: What they are and how they might be used in treating liver disease. Curr Gastroenterol Rep 2012; 14: 55-62.
15. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006; 439: 484-489. (Pubitemid 43152840)
16. Cannon B, Nedergaard J. Brown adipose tissue: Function and physiological significance. Physiol Rev 2004; 84: 277-359. (Pubitemid 38054374)
17. Wu J, Cohen P, Spiegelman BM. Adaptive thermogenesis in adipocytes: Is beige the new brown? Genes Dev 2013; 27: 234-250.
18. Rothwell NJ, Stock MJ. A role for brown adipose tissue in diet-induced thermogenesis. Nature 1979; 281: 31-35. (Pubitemid 9247988)
19. da-Silva WS, Ribich S, Arrojo e Drigo R, Castillo M, Patti ME, Bianco AC. The chemical chaperones tauroursodeoxycholic and 4-phenylbutyric acid accelerate thyroid hormone activation and energy expenditure. FEBS Lett 2011; 585: 539-544.
20. Watanabe M, Horai Y, Houten SM, Morimoto K, Sugizaki T, Arita E et al. Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem 2011; 286: 26913-26920.
21. Zingaretti MC, Crosta F, Vitali A, Guerrieri M, Frontini A, Cannon B et al. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J 2009; 23: 3113-3120.
22. Young P, Arch JR, Ashwell M. Brown adipose tissue in the parametrial fat pad of the mouse. FEBS Lett 1984; 167: 10-14. (Pubitemid 14198825)
23. Loncar D. Convertible adipose tissue in mice. Cell Tissue Res 1991; 266: 149-161.
24. Cousin B, Cinti S, Morroni M, Raimbault S, Ricquier D, Penicaud L et al. Occurrence of brown adipocytes in rat white adipose tissue: Molecular and morphological characterization. J Cell Sci 1992; 103: 931-942. (Pubitemid 23042237)
25. Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B, Nedergaard J. Chronic peroxisome proliferator-Activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem 2010; 285: 7153-7164.
26. Frontini A, Vitali A, Perugini J, Murano I, Romiti C, Ricquier D et al. White-To-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma. Biochim Biophys Acta 2013; 1831: 950-959.
27. Jespersen NZ, Larsen TJ, Peijs L, Daugaard S, Homoe P, Loft A et al. A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab 2013; 17: 798-805.
28. Nedergaard J, Cannon B. UCP1 mRNA does not produce heat. Biochim Biophys Acta 2013; 1831: 943-949.
29. Kuda O, Jelenik T, Jilkova Z, Flachs P, Rossmeisl M, Hensler M et al. n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 2009; 52: 941-951.
30. Medrikova D, Jilkova ZM, Bardova K, Janovska P, Rossmeisl M, Kopecky J. Sex differences during the course of diet-induced obesity in mice: Adipose tissue expandability and glycemic control. Int J Obes 2012; 36: 262-272.
31. Rossmeisl M, Jelenik T, Jilkova Z, Slamova K, Kus V, Hensler M et al. Prevention and reversal of obesity and glucose intolerance in mice by DHA derivatives. Obesity 2009; 17: 1023-1031.
32. Salmon DM, Flatt JP. Effect of dietary fat content on the incidence of obesity among ad libitum fed mice. Int J Obes 1985; 9: 443-449. (Pubitemid 16189471)
33. Kopecky J, Rossmeisl M, Hodny Z, Syrovy I, Horakova M, Kolarova P. Reduction of dietary obesity in aP2-Ucp transgenic mice: Mechanism and adipose tissue morphology. Am J Physiol 1996; 270: E776-E786.
34. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85. (Pubitemid 16258399)
35. Kus V, Prazak T, Brauner P, Hensler M, Kuda O, Flachs P et al. Induction of muscle thermogenesis by high-fat diet in mice: Association with obesity-resistance. Am J Physiol Endocrinol Metab 2008; 295: E356-E367.
36. Flachs P, Ruhl R, Hensler M, Janovska P, Zouhar P, Kus V et al. Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. Diabetologia 2011; 54: 2626-2638.
37. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949; 109: 1-9.
38. Even PC, Nadkarni NA. Indirect calorimetry in laboratory mice and rats: Principles, practical considerations, interpretation and perspectives. Am J Physiol Regul Integr Comp Physiol 2012; 303: R459-R476.
39. Seale P, Conroe HM, Estall J, Kajimura S, Frontini A, Ishibashi J et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 2011; 121: 96-105.
40. Butler AA, Kozak LP. A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 2010; 59: 323-329.
41. Himms-Hagen J. On raising energy expenditure in ob/ob mice. Science 1997; 276: 1132-1133. (Pubitemid 27218125)
42. Kaiyala KJ, Schwartz MW. Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis. Diabetes 2011; 60: 17-23.
43. Greiner T, Backhed F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab 2011; 22: 117-123. .